Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-06-21 00:00:00 ET · period of report 2023-06-16 · accession 0001209191-23-038836 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-21 | 2023-06-16 | RXRX | CHAVEZ R. MARTIN | Dir | A - Grant | $0.00 | +12.6K | 51.0K | +33% | $0 |
| D | 2023-06-21 | 2023-06-16 | RXRX | CHAVEZ R. MARTIN | Dir | A - Grant | $0.00 | +25.2K | 25.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-16 | A | A | 12,612 | $0.00 | 51,017 | D | — | — | (F1) Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 16, 2024 or the day prior to the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-06-16 | A | A | 25,224 | $0.00 | 25,224 | D | $8.92 · 2024-06-16 to 2033-06-16 | 25,224 Class A Common Stock | (F2) The shares subject to this option will vest and become exercisable on the earlier of June 16, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer. |